Saula Checquolo (S Checquolo)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 8

Top Topics

Acute Lymphoblastic Leukemia

Endoplasmic Reticulum Stress

Cancer Stem Cells

Top Venues

Journal of oncology

Stem cells international

This page only lists publications with an associated author ORCID identifier.

Publications

Nadezda Zhdanovskaya, Sara Lazzari, Diego Caprioglio, Mariarosaria Firrincieli, Chiara Maioli, Eleonora Pace, Daniela Imperio, Claudio Talora, Diana Bellavia, Saula Checquolo, Mattia Mori, Isabella Screpanti, Alberto Minassi, Rocco Palermo
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL. Cancers 14 (23) (2022)
Nadezda Zhdanovskaya, Sara Lazzari, Diego Caprioglio, Mariarosaria Firrincieli, Chiara Maioli, Eleonora Pace, Daniela Imperio, Claudio Talora, Diana Bellavia, Saula Checquolo, Mattia Mori, Isabella Screpanti, Alberto Minassi, Rocco Palermo
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL. Cancers 14 (23) (2022)
Nadezda Zhdanovskaya, Sara Lazzari, Diego Caprioglio, Mariarosaria Firrincieli, Chiara Maioli, Eleonora Pace, Daniela Imperio, Claudio Talora, Diana Bellavia, Saula Checquolo, Mattia Mori, Isabella Screpanti, Alberto Minassi, Rocco Palermo
Identification of a Novel Curcumin Derivative Influencing Notch Pathway and DNA Damage as a Potential Therapeutic Agent in T-ALL. Cancers 14 (23) (2022)
Maria Valeria Giuli, Giulia Diluvio, Eugenia Giuliani, Giulia Franciosa, Laura Di Magno, Maria Gemma Pignataro, Luca Tottone, Carmine Nicoletti, Zein Mersini Besharat, Giovanna Peruzzi, Maria Pelullo, Rocco Palermo, Gianluca Canettieri, Claudio Talora, Giulia d'Amati, Diana Bellavia, Isabella Screpanti, Saula Checquolo
Notch3 contributes to T-cell leukemia growth via regulation of the unfolded protein response. Oncogenesis 9 (10) (2020)
Maria Valeria Giuli, Patrizia Nadia Hanieh, Eugenia Giuliani, Federica Rinaldi, Carlotta Marianecci, Isabella Screpanti, Saula Checquolo, Maria Carafa
Current Trends in ATRA Delivery for Cancer Therapy. Pharmaceutics 12 (8) (2020)
Maria Valeria Giuli, Eugenia Giuliani, Isabella Screpanti, Diana Bellavia, Saula Checquolo
Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype. Journal of oncology 2019 (2019)
Simona Ceccarelli, Francesca Megiorni, Diana Bellavia, Cinzia Marchese, Isabella Screpanti, Saula Checquolo
Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells. Stem cells international 2019 (2019)
Giulia Diluvio, Francesca Del Gaudio, Maria Valeria Giuli, Giulia Franciosa, Eugenia Giuliani, Rocco Palermo, Zein Mersini Besharat, Maria Gemma Pignataro, Alessandra Vacca, Giulia d'Amati, Marella Maroder, Claudio Talora, Carlo Capalbo, Diana Bellavia, Saula Checquolo
NOTCH3 inactivation increases triple negative breast cancer sensitivity to gefitinib by promoting EGFR tyrosine dephosphorylation and its intracellular arrest. Oncogenesis 7 (5) (2018)